TELA Bio (TELA) Equity Average (2019 - 2025)
Historic Equity Average for Bio (TELA) over the last 7 years, with Q3 2025 value amounting to $5.4 million.
- Bio's Equity Average rose 41572.6% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 41572.6%. This contributed to the annual value of $23.7 million for FY2024, which is 4264.75% up from last year.
- Bio's Equity Average amounted to $5.4 million in Q3 2025, which was up 41572.6% from $13.7 million recorded in Q2 2025.
- Bio's 5-year Equity Average high stood at $45.4 million for Q1 2021, and its period low was -$1.7 million during Q3 2024.
- Over the past 5 years, Bio's median Equity Average value was $16.6 million (recorded in 2024), while the average stood at $18.7 million.
- As far as peak fluctuations go, Bio's Equity Average tumbled by 10482.16% in 2024, and later surged by 41572.6% in 2025.
- Quarter analysis of 5 years shows Bio's Equity Average stood at $23.9 million in 2021, then fell by 21.37% to $18.8 million in 2022, then surged by 31.45% to $24.7 million in 2023, then crashed by 55.12% to $11.1 million in 2024, then crashed by 51.59% to $5.4 million in 2025.
- Its Equity Average was $5.4 million in Q3 2025, compared to $13.7 million in Q2 2025 and $23.3 million in Q1 2025.